I
GILD icon

INVST’s Gilead Sciences GILD Stock Holding History

INVST’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,733
Closed -$985K – 174
2022
Q4 		$985K Sell
11,733
-1,007
-8% -$79.7K 0.15% 81
2022
Q3 		$821K Buy
12,740
+240
+2% +$15.1K 0.14% 85
2022
Q2 		$789K Buy
12,500
+3,862
+45% +$239K 0.12% 96
2022
Q1 		$533K Sell
8,638
-8
-0.1% -$511 0.09% 105
2021
Q4 		$530K Buy
+8,646
New +$596K 0.08% 103

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

INVST's GILD Position: Q1 2023 in Review

INVST sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 11,733 shares — an estimated $985K sold.

INVST first reported a position in GILD in Q4 2021 and held it in 5 quarters. The position peaked at $985K in Q4 2022. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • INVST reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
  • INVST sold 11,733 Gilead Sciences shares in Q1 2023, an estimated $985K.
  • INVST first reported a position in Gilead Sciences in Q4 2021 and held it in 5 quarters.
  • INVST's Gilead Sciences position peaked at $985K in Q4 2022.
  • 1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on INVST's 13F filing for Q1 2023, filed 28 Apr 2023.